CN105638642A - 一种免疫细胞冻存液及其应用 - Google Patents
一种免疫细胞冻存液及其应用 Download PDFInfo
- Publication number
- CN105638642A CN105638642A CN201610056699.2A CN201610056699A CN105638642A CN 105638642 A CN105638642 A CN 105638642A CN 201610056699 A CN201610056699 A CN 201610056699A CN 105638642 A CN105638642 A CN 105638642A
- Authority
- CN
- China
- Prior art keywords
- immunocyte
- stock solution
- frozen stock
- cell
- culture medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000005138 cryopreservation Methods 0.000 title claims abstract description 38
- 210000002865 immune cell Anatomy 0.000 title claims abstract description 10
- 210000004027 cell Anatomy 0.000 claims abstract description 53
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 41
- 239000001963 growth medium Substances 0.000 claims abstract description 37
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 36
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 33
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 33
- 238000011084 recovery Methods 0.000 claims abstract description 20
- 238000002347 injection Methods 0.000 claims abstract description 17
- 239000007924 injection Substances 0.000 claims abstract description 17
- 239000011780 sodium chloride Substances 0.000 claims abstract description 17
- 210000002966 serum Anatomy 0.000 claims abstract description 15
- 239000011550 stock solution Substances 0.000 claims description 106
- 210000004698 lymphocyte Anatomy 0.000 claims description 23
- 102000008100 Human Serum Albumin Human genes 0.000 claims description 21
- 108091006905 Human Serum Albumin Proteins 0.000 claims description 21
- 239000007640 basal medium Substances 0.000 claims description 21
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 20
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 20
- 210000002381 plasma Anatomy 0.000 claims description 19
- 239000012980 RPMI-1640 medium Substances 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 13
- 239000006285 cell suspension Substances 0.000 claims description 11
- 229910052757 nitrogen Inorganic materials 0.000 claims description 10
- 210000000822 natural killer cell Anatomy 0.000 claims description 9
- 238000007710 freezing Methods 0.000 claims description 8
- 230000008014 freezing Effects 0.000 claims description 8
- 210000004369 blood Anatomy 0.000 claims description 7
- 239000008280 blood Substances 0.000 claims description 7
- 210000005259 peripheral blood Anatomy 0.000 claims description 7
- 239000011886 peripheral blood Substances 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 210000001744 T-lymphocyte Anatomy 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 238000005119 centrifugation Methods 0.000 claims description 5
- 210000004700 fetal blood Anatomy 0.000 claims description 5
- 239000000155 melt Substances 0.000 claims description 5
- 230000001681 protective effect Effects 0.000 claims description 5
- 230000003044 adaptive effect Effects 0.000 claims description 2
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 claims description 2
- 210000000581 natural killer T-cell Anatomy 0.000 claims 1
- 241001465754 Metazoa Species 0.000 abstract description 14
- 102000004169 proteins and genes Human genes 0.000 abstract description 7
- 108090000623 proteins and genes Proteins 0.000 abstract description 7
- 230000004083 survival effect Effects 0.000 abstract description 7
- 239000000243 solution Substances 0.000 abstract description 6
- 230000004071 biological effect Effects 0.000 abstract description 4
- 101001002657 Homo sapiens Interleukin-2 Proteins 0.000 abstract 1
- 238000011109 contamination Methods 0.000 abstract 1
- 102000055277 human IL2 Human genes 0.000 abstract 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 40
- 230000000052 comparative effect Effects 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 210000005087 mononuclear cell Anatomy 0.000 description 7
- 102000000588 Interleukin-2 Human genes 0.000 description 6
- 108010002350 Interleukin-2 Proteins 0.000 description 6
- 230000002631 hypothermal effect Effects 0.000 description 6
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 4
- 238000009169 immunotherapy Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 239000002577 cryoprotective agent Substances 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 230000003321 amplification Effects 0.000 description 2
- 210000003719 b-lymphocyte Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 206010011409 Cross infection Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000012930 cell culture fluid Substances 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610056699.2A CN105638642B (zh) | 2016-01-27 | 2016-01-27 | 一种免疫细胞冻存液及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610056699.2A CN105638642B (zh) | 2016-01-27 | 2016-01-27 | 一种免疫细胞冻存液及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105638642A true CN105638642A (zh) | 2016-06-08 |
CN105638642B CN105638642B (zh) | 2018-10-19 |
Family
ID=56487992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610056699.2A Active CN105638642B (zh) | 2016-01-27 | 2016-01-27 | 一种免疫细胞冻存液及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105638642B (zh) |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105935051A (zh) * | 2016-07-15 | 2016-09-14 | 广州姿生生物科技有限公司 | 一种免疫细胞保存液 |
CN105961374A (zh) * | 2016-07-04 | 2016-09-28 | 深圳市合康生物科技股份有限公司 | 细胞冻存液 |
CN105994253A (zh) * | 2016-07-15 | 2016-10-12 | 广州姿生生物科技有限公司 | 一种免疫细胞冻存液 |
CN106942200A (zh) * | 2017-03-24 | 2017-07-14 | 深圳市合康生物科技股份有限公司 | 一种冻存保护液及其应用 |
CN107047536A (zh) * | 2016-11-22 | 2017-08-18 | 浙江三誉生物科技有限公司 | 一种细胞保存液及其应用 |
CN107047541A (zh) * | 2017-05-31 | 2017-08-18 | 东莞市保莱生物科技有限公司 | 一种免疫细胞冻存液及免疫细胞冻存方法 |
CN107258766A (zh) * | 2017-06-18 | 2017-10-20 | 广东博溪生物科技有限公司 | 一种细胞冻存方法及细胞冻存液 |
CN108064840A (zh) * | 2017-12-28 | 2018-05-25 | 重庆斯德姆生物技术有限公司 | 一种nkt细胞冻存液及其制备方法 |
CN108617640A (zh) * | 2018-06-26 | 2018-10-09 | 吉林省太阳鸟再生医学工程有限责任公司 | 一种脐血单个核细胞冻存液及其应用 |
CN108651439A (zh) * | 2018-04-13 | 2018-10-16 | 上海韵飞生物科技有限公司 | 一种外周血单核细胞完全无血清冻存液及其方法 |
CN110679588A (zh) * | 2019-10-23 | 2020-01-14 | 厦门生命互联科技有限公司 | 一种嵌合抗原受体t细胞冻存介质及用途 |
CN111602648A (zh) * | 2020-04-26 | 2020-09-01 | 河南侨创生命科技有限公司 | 一种免疫细胞无血清冻存液及冻存方法 |
CN111685108A (zh) * | 2020-07-29 | 2020-09-22 | 珠海贝索细胞科学技术有限公司 | 一种人类外周血免疫细胞冻存高效稳定剂及应用和冻存方法 |
CN113615681A (zh) * | 2021-08-27 | 2021-11-09 | 郑州源创吉因实业有限公司 | 一种免疫细胞的冻存液及冻存方法 |
CN114521549A (zh) * | 2022-02-28 | 2022-05-24 | 四川中科博瑞生物科技有限公司 | 一种免疫细胞冻存液和应用及细胞冻存方法和复苏方法 |
CN114615886A (zh) * | 2019-08-29 | 2022-06-10 | 得克萨斯大学体系董事会 | 细胞冷冻保存培养基 |
CN114667999A (zh) * | 2022-05-27 | 2022-06-28 | 广东先康达生物科技有限公司 | 一种免疫细胞冻存稳定剂、冻存液及冻存方法 |
CN115005199A (zh) * | 2022-07-14 | 2022-09-06 | 北京鼎成肽源生物技术有限公司 | 一种自然杀伤细胞的冻存液、冻存方法和应用 |
CN115039763A (zh) * | 2022-07-15 | 2022-09-13 | 北京大学第三医院(北京大学第三临床医学院) | 一种免疫细胞冻存液 |
CN115088708A (zh) * | 2022-07-22 | 2022-09-23 | 厦门锐杰天川生物科技有限公司 | 外周血单个核细胞长期保存方法 |
CN115590013A (zh) * | 2021-07-07 | 2023-01-13 | 北京鼎成肽源生物技术有限公司(Cn) | 一种自然杀伤细胞的冻存液、冻存方法和应用 |
CN115777686A (zh) * | 2022-09-06 | 2023-03-14 | 北京唐颐惠康生物医学技术有限公司 | 一种细胞冻存液及其制备方法和应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001036589A2 (en) * | 1999-11-17 | 2001-05-25 | University Of Rochester | Human ex vivo immune system |
CN1715400A (zh) * | 2004-07-01 | 2006-01-04 | 宋清华 | 淋巴细胞冷冻保存的方法 |
CN102273438A (zh) * | 2011-08-15 | 2011-12-14 | 上海安集协康生物技术有限公司 | 一种药用细胞注射液的冻存保护辅料 |
CN104694472A (zh) * | 2015-02-13 | 2015-06-10 | 杭州易文赛生物技术有限公司 | 一种扩增并冻存的自然杀伤细胞的方法 |
CN104920340A (zh) * | 2015-07-15 | 2015-09-23 | 广州赛莱拉干细胞科技股份有限公司 | 一种免疫细胞保存液及其应用 |
-
2016
- 2016-01-27 CN CN201610056699.2A patent/CN105638642B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001036589A2 (en) * | 1999-11-17 | 2001-05-25 | University Of Rochester | Human ex vivo immune system |
CN1715400A (zh) * | 2004-07-01 | 2006-01-04 | 宋清华 | 淋巴细胞冷冻保存的方法 |
CN102273438A (zh) * | 2011-08-15 | 2011-12-14 | 上海安集协康生物技术有限公司 | 一种药用细胞注射液的冻存保护辅料 |
CN104694472A (zh) * | 2015-02-13 | 2015-06-10 | 杭州易文赛生物技术有限公司 | 一种扩增并冻存的自然杀伤细胞的方法 |
CN104920340A (zh) * | 2015-07-15 | 2015-09-23 | 广州赛莱拉干细胞科技股份有限公司 | 一种免疫细胞保存液及其应用 |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105961374A (zh) * | 2016-07-04 | 2016-09-28 | 深圳市合康生物科技股份有限公司 | 细胞冻存液 |
CN105935051A (zh) * | 2016-07-15 | 2016-09-14 | 广州姿生生物科技有限公司 | 一种免疫细胞保存液 |
CN105994253A (zh) * | 2016-07-15 | 2016-10-12 | 广州姿生生物科技有限公司 | 一种免疫细胞冻存液 |
CN107047536A (zh) * | 2016-11-22 | 2017-08-18 | 浙江三誉生物科技有限公司 | 一种细胞保存液及其应用 |
CN106942200A (zh) * | 2017-03-24 | 2017-07-14 | 深圳市合康生物科技股份有限公司 | 一种冻存保护液及其应用 |
CN107047541A (zh) * | 2017-05-31 | 2017-08-18 | 东莞市保莱生物科技有限公司 | 一种免疫细胞冻存液及免疫细胞冻存方法 |
CN107258766A (zh) * | 2017-06-18 | 2017-10-20 | 广东博溪生物科技有限公司 | 一种细胞冻存方法及细胞冻存液 |
CN108064840A (zh) * | 2017-12-28 | 2018-05-25 | 重庆斯德姆生物技术有限公司 | 一种nkt细胞冻存液及其制备方法 |
CN108064840B (zh) * | 2017-12-28 | 2021-01-19 | 重庆斯德姆生物技术有限公司 | 一种nkt细胞冻存液及其制备方法 |
CN108651439A (zh) * | 2018-04-13 | 2018-10-16 | 上海韵飞生物科技有限公司 | 一种外周血单核细胞完全无血清冻存液及其方法 |
CN108617640A (zh) * | 2018-06-26 | 2018-10-09 | 吉林省太阳鸟再生医学工程有限责任公司 | 一种脐血单个核细胞冻存液及其应用 |
CN114615886A (zh) * | 2019-08-29 | 2022-06-10 | 得克萨斯大学体系董事会 | 细胞冷冻保存培养基 |
EP4021180A4 (en) * | 2019-08-29 | 2023-11-08 | Board of Regents, The University of Texas System | CELL CRYOPRESERVATION MEDIUM |
CN110679588A (zh) * | 2019-10-23 | 2020-01-14 | 厦门生命互联科技有限公司 | 一种嵌合抗原受体t细胞冻存介质及用途 |
CN111602648A (zh) * | 2020-04-26 | 2020-09-01 | 河南侨创生命科技有限公司 | 一种免疫细胞无血清冻存液及冻存方法 |
CN111602648B (zh) * | 2020-04-26 | 2021-04-06 | 河南侨创生命科技有限公司 | 一种免疫细胞无血清冻存液及冻存方法 |
CN111685108A (zh) * | 2020-07-29 | 2020-09-22 | 珠海贝索细胞科学技术有限公司 | 一种人类外周血免疫细胞冻存高效稳定剂及应用和冻存方法 |
CN115590013A (zh) * | 2021-07-07 | 2023-01-13 | 北京鼎成肽源生物技术有限公司(Cn) | 一种自然杀伤细胞的冻存液、冻存方法和应用 |
CN115590013B (zh) * | 2021-07-07 | 2024-08-09 | 北京鼎成肽源生物技术有限公司 | 一种自然杀伤细胞的冻存液、冻存方法和应用 |
CN113615681A (zh) * | 2021-08-27 | 2021-11-09 | 郑州源创吉因实业有限公司 | 一种免疫细胞的冻存液及冻存方法 |
CN114521549A (zh) * | 2022-02-28 | 2022-05-24 | 四川中科博瑞生物科技有限公司 | 一种免疫细胞冻存液和应用及细胞冻存方法和复苏方法 |
CN114667999A (zh) * | 2022-05-27 | 2022-06-28 | 广东先康达生物科技有限公司 | 一种免疫细胞冻存稳定剂、冻存液及冻存方法 |
CN115005199A (zh) * | 2022-07-14 | 2022-09-06 | 北京鼎成肽源生物技术有限公司 | 一种自然杀伤细胞的冻存液、冻存方法和应用 |
CN115005199B (zh) * | 2022-07-14 | 2023-08-22 | 北京鼎成肽源生物技术有限公司 | 一种自然杀伤细胞的冻存液、冻存方法和应用 |
CN115039763A (zh) * | 2022-07-15 | 2022-09-13 | 北京大学第三医院(北京大学第三临床医学院) | 一种免疫细胞冻存液 |
CN115088708A (zh) * | 2022-07-22 | 2022-09-23 | 厦门锐杰天川生物科技有限公司 | 外周血单个核细胞长期保存方法 |
CN115777686A (zh) * | 2022-09-06 | 2023-03-14 | 北京唐颐惠康生物医学技术有限公司 | 一种细胞冻存液及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN105638642B (zh) | 2018-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105638642A (zh) | 一种免疫细胞冻存液及其应用 | |
CN108651439A (zh) | 一种外周血单核细胞完全无血清冻存液及其方法 | |
CN105660606B (zh) | 一种细胞冻存液 | |
CN102487939B (zh) | 一种间充质干细胞储存液 | |
WO2009120996A1 (en) | Mehtod, system, and apparatus for hypothermic collection, storage, transport and banking of birth tissue | |
CN111248191A (zh) | 一种常温细胞保存液和注射用细胞制剂 | |
CN102669087A (zh) | 一种外周血单个核细胞的冻存液及冻存方法 | |
CN106967675A (zh) | 一种从胎盘中分离提取造血干细胞的方法 | |
ES2807897T3 (es) | Terapia con células madre basada en células madre procedentes de tejido adiposo | |
CN110140716A (zh) | 一种外周血单个核细胞改良冻存液 | |
CN105462922A (zh) | 一种增加免疫细胞得率的方法 | |
CN111602648B (zh) | 一种免疫细胞无血清冻存液及冻存方法 | |
CN103004751A (zh) | 一种造血干细胞冻存的方法及保护剂 | |
CN111587877A (zh) | 干细胞冻存保护剂、制备方法及应用 | |
Berz et al. | Cryopreservation of hematopoietic and non-hematopoietic stem cells–a review for the clinician | |
WO2020033959A1 (en) | Cryopreservation medium for umbilical cord mscs derived from wharton's jelly | |
US20110044959A1 (en) | Novel composition of stem cells for transplantation tolerance | |
CN105613484B (zh) | 巨核祖细胞冻存液及其应用 | |
CN107787960B (zh) | 视网膜色素上皮细胞的冻存液及其应用 | |
Buckler et al. | Technological developments for small-scale downstream processing of cell therapies | |
Mavin et al. | Do cryopreserved regulatory T cells retain their suppressive potency? | |
CN114009425A (zh) | 一种免疫细胞玻璃化冻存保护液及其冻存方法 | |
CN115088708B (zh) | 外周血单个核细胞长期保存方法 | |
Weinberg | Hematopoietic progenitor cell products derived from bone marrow and peripheral blood | |
Marwaha | Transfusion medicine in India: Expanding horizons |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190228 Address after: 100000 Beijing Changping District Huilongguan Town Science and Technology Park Huilongguan Zhongguancun Life Science Park Road, Building A, 2nd Floor Patentee after: Juli Biotechnology (Beijing) Co.,Ltd. Address before: Room 516, Building 1132, Liuxiang Road, Jiading District, Shanghai 201802 Patentee before: SHANGHAI RUNQUAN BIOTECHNOLOGY CO.,LTD. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: Room 701, Unit 1, Building 8, No. 88 Kechuang 6th Street, Beijing Economic and Technological Development Zone, Daxing District, Beijing, 100176 Patentee after: Juli Biotechnology (Beijing) Co.,Ltd. Country or region after: China Address before: 100000 Beijing Changping District Huilongguan Town Science and Technology Park Huilongguan Zhongguancun Life Science Park Road, Building A, 2nd Floor Patentee before: Juli Biotechnology (Beijing) Co.,Ltd. Country or region before: China |